US OptionsDetailed Quotes
ADAP241115P2000
- 0.00
- 0.000.00%
15min DelayClose Oct 31 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover423.05%IV-175.86%PremiumNov 15, 2024Expiry Date1.27Intrinsic Value100Multiplier14DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7834Delta0.4847Gamma0.55Leverage Ratio-0.0060Theta-0.0006Rho-0.43Eff Leverage0.0004Vega
Adaptimmune Therapeutics Stock Discussion
On September 23, 2024, Adaptimmune Therapeutics plc (the “Company”) entered into a Mutual Release and Resolution Agreement (the “Agreement”) with Genentech Inc and F. Hoffmann-La Roche Ltd, (together “Genentech”). The parties entered into the Agreement following notice of termination of their Collaboration and License Agreement dated September 3, 2021 (the “Collaboration Agreement”) on April 8,...
so the spike in cash is from financing, fyi
after the product is approved, profitable, it's your time to shine.
$Adaptimmune Therapeutics (ADAP.US)$
come on
😩. I wish I had more capital. This is about to run hard.
No comment yet